Can Ritlecitinib treat seborrheic alopecia?

Ritlecitinib (Ritlecitinib) is the latest drug approved by the U.S. Food and Drug Administration (FDA) to treat severe alopecia areata. Ritexitinib is currently not approved for the treatment of seborrheic alopecia. Common treatments for seborrheic alopecia include antifungal shampoos, topical hormonal medications, antibiotics, or other treatments, depending on the individual case. In a clinical study on ritexitinib, 3-month results showed that patients treated with this drug achieved scalp hair coverage80% or more% of adults and teens who use this medicine see significant hair regrowth covering 80% or more of their scalp in less than 6 months.